Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1686 USD | +1.51% | -6.33% | +20.43% |
May. 20 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
Feb. 15 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+20.43% | 177M | |
+16.93% | 42.79B | |
+22.20% | 22.81B | |
+16.96% | 15.04B | |
+18.51% | 14.49B | |
+51.63% | 12.65B | |
-0.05% | 6.79B | |
-11.45% | 6.74B | |
-8.87% | 5.73B | |
+14.55% | 5.47B |
- Stock Market
- Equities
- ELTP Stock
- News Elite Pharmaceuticals, Inc.
- Transcript : Elite Pharmaceuticals, Inc., 2023 Earnings Call, Jun 30, 2023